A Phase 1, Open-Label, Parallel, Sequential, Multi-part Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of an Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult Volunteers
Latest Information Update: 30 Jul 2019
At a glance
- Drugs Colesevelam (Primary) ; Digoxin; Ethinylestradiol/norethisterone; Glibenclamide; Levothyroxine sodium
- Indications Gastro-oesophageal reflux
- Focus Pharmacokinetics
- Sponsors Ironwood Pharmaceuticals
Most Recent Events
- 26 Jul 2019 Status changed from recruiting to completed.
- 14 May 2019 Planned End Date changed from 14 Jun 2019 to 12 Jun 2019.
- 14 May 2019 Status changed from not yet recruiting to recruiting.